TOI · Oncology Institute, Inc.
$6.20
+0.04 (+0.65%)
At close · Aug 11
Market Cap
$522.83M
Shares
101.92M
Oncology Institute, Inc. Earnings Call Transcripts
Every quarterly earnings call for Oncology Institute, Inc. (TOI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲24.3%
$64.98M
−$2.67M
'22 Q3
22-11-15
▲36.6%
$71.42M
−$11.01M
'22 Q4
23-03-09
▲38.1%
$76.19M
−$30.00M
'23 Q1
23-05-10
▲31.7%
$80.22M
−$16.90M
'23 Q2
23-08-09
▲26.3%
$82.03M
−$17.42M
'23 Q3
23-11-08
▲20.1%
$85.79M
−$18.75M
'23 Q4
24-03-27
▲24.2%
$94.67M
−$19.89M
'24 Q1
24-04-03
▲22.9%
$98.58M
−$15.48M
'24 Q2
24-08-13
▲21.8%
$99.90M
−$16.11M
'24 Q3
24-11-13
▲16.9%
$100.27M
−$13.18M
'24 Q4
25-03-24
▲10.3%
$104.41M
−$19.59M
'25 Q1
25-05-14
▲21.5%
$119.80M
−$17.01M
'25 Q2
25-08-13
▲36.7%
$136.56M
−$16.50M
'25 Q3
25-11-13
▲41.6%
$141.96M
−$7.51M
'25 Q4
25-12-31
▲41.2%
$147.44M
−$2.49M
'26 Q1
26-05-07
LATEST
▲34.6%
$161.28M
−$9.79M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Oncology Institute, Inc. Q2 FY2026 Earnings Call
Revenue
$161.28M
▲ 34.6% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Oncology Institute, Inc. Q1 FY2026 Earnings Call
Confident tone
Florida market expansion and profitability
Executive team expansion
Revenue scale and capitated lives growth
Revenue
$147.44M
▲ 41.2% YoY Diluted EPS
$-0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Oncology Institute, Inc. Q4 FY2025 Earnings Call
Confident tone
Capitated/Delegated Care Model Expansion
Florida Market Growth (Elevance, Humana, CarePlus)
Part D Pharmacy / Dispensing Platform
Revenue
$141.96M*
▲ 41.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Oncology Institute, Inc. Q3 FY2025 Earnings Call
Confident tone
Macro and policy environment
Pharmacy business expansion
AI initiatives and operational efficiency
Revenue
$136.56M
▲ 36.7% YoY Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Oncology Institute, Inc. Q2 FY2025 Earnings Call
Confident tone
Pharmacy business growth
Florida market expansion
Fully delegated model explanation
Revenue
$119.80M
▲ 21.5% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Oncology Institute, Inc. Q1 FY2025 Earnings Call
Confident tone
Capitation contract wins
Fee-for-service recovery
Path to profitability and cash flow
Revenue
$104.41M
▲ 10.3% YoY Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-24
Oncology Institute, Inc. Q4 FY2024 Earnings Call
Revenue
$100.27M*
▲ 16.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Oncology Institute, Inc. Q3 FY2024 Earnings Call
Positive tone
Liquidity and balance sheet
Cost optimization and SG&A reduction
Capitated contract growth
Revenue
$99.90M
▲ 21.8% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Oncology Institute, Inc. Q2 FY2024 Earnings Call
Positive tone
DIR fee impact and drug margin compression
Capitation contracts and value-based care growth
Profitability path and guidance
Revenue
$98.58M
▲ 22.9% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-03
Oncology Institute, Inc. Q1 FY2024 Earnings Call
Positive tone
Capitation and value-based contracts
Strategic priorities and market expansion
Cash burn and liquidity
Revenue
$94.67M
▲ 24.2% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Oncology Institute, Inc. Q4 FY2023 Earnings Call
Confident tone
Florida Market Expansion
DIR Fees and Drug Margin Pressure
Value-Based Contracts and Risk Expansion
Revenue
$85.79M*
▲ 20.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Oncology Institute, Inc. Q3 FY2023 Earnings Call
Revenue
$82.03M
▲ 26.3% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Oncology Institute, Inc. Q2 FY2023 Earnings Call
Revenue
$80.22M
▲ 31.7% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Oncology Institute, Inc. Q1 FY2023 Earnings Call
Revenue
$76.19M
▲ 38.1% YoY Diluted EPS
$-0.33
▼ 257.1% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
Oncology Institute, Inc. Q4 FY2022 Earnings Call
Revenue
$71.42M*
▲ 36.6% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-15
Oncology Institute, Inc. Q3 FY2022 Earnings Call
Revenue
$64.98M
▲ 24.3% YoY Diluted EPS
$-0.17
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-16
Oncology Institute, Inc. Q2 FY2022 Earnings Call
Revenue
$60.92M
▲ 22.2% YoY Diluted EPS
$-0.06
▼ 220% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Oncology Institute, Inc. Q1 FY2022 Earnings Call
Revenue
$55.16M
▲ 13.5% YoY Diluted EPS
$0.21
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-11
Oncology Institute, Inc. Q4 FY2021 Earnings Call
Revenue
$52.30M*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–19 of 19 earnings calls
Key facts
CIK
1799191
CUSIP
68236X100
13F (30d)
127 filings
126 filers
Visit website
Investor relations